An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Determination of Protective Levels of Maternal Antibody to Group B Streptococcus

Investigators
Lin, Feng-Ying
Institutions
DHHS/NIH - National Institute of Child Health and Human Development
Start date
2000
End date
2000
Objective
This prospective case-control study was conducted in six academic centers from 1995 to 1999. Two groups of infants were recruited; infants who developed early-onset Group B Streptococcus (GBS) disease ("cases") and infants who did not have GBS disease despite being surface colonized ("controls"). Maternal sera and cord sera were collected for serotyping.
More information
Medical records of cases and controls were reviewed. A total of 132 cases, 620 heavily colonized (greater than or equal to 3 sites) and 1018 lightly colonized (greater than or equal to 2 sites) were identified. Titers of IgG anti-antibodies to the infecting GBS serotype will be measured. Cases and controls will be contrasted for the presence of antibody at various titers, both in simple analyses and in multivariate analyses that control for potentially confounding variables. An additional study was conducted to evaluate the effectiveness of risk-based intrapartum antibiotic prophylaxis for prevention of early-onset GBS disease. We compared 109 early-onset GBS cases with 207 matched controls without GBS disease. Both cases and controls were from births to mothers with greater than or equal to one risk factor to GBS disease, as defined by ACOG guidelines. Maternal and infant's medical records were reviewed by chart abstractors who were kept blinded to the case and control status. Antibiotic effectiveness was evaluated by calculating the odds ratio for the comparison of the receipt of intrapartum prophylactic antibiotics in mothers of cases vs. mothers of controls.
Funding Source
Nat'l. Inst. of Child Health and Human Devel.
Project number
1Z01HD002519-06
Categories
Bacterial Pathogens
Prevention and Control